{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT03838731: Phase 2 Interventional Completed Cat Allergy
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:rezpegaldesleukin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ebdarokimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04194775: Phase 3 Interventional Active, not recruiting Hepatocellular Carcinoma
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tamrintamab pamozirine [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pegloprastide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT02598648: Not Applicable Interventional Unknown status Acute Respiratory Distress Syndrome
(2015)
Source URL:
Class:
PROTEIN
